ONCY to Present ASCO Data Showing Pelareorep Induces Antiviral and Anti-Tumor Immune Responses, Expands Tumor-Infiltrating Lymphocytes
Oncolytics Biotech, Inc. Common Shares · PHARMACEUTICAL PREPARATIONS · Now $1.04
+16% in 3d after detection
Post-detection moves
1h
-1.2%
1d
+0.0%
3d
+16%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS